Luoxin Pharmaceutical plans to raise no more than 842.4 million yuan through a private placement of shares
I'm LongbridgeAI, I can summarize articles.
Luoxin Pharmaceutical plans to issue A-shares to specific targets in the 2025 fiscal year, with a total fundraising amount not exceeding 842.4 million yuan. The number of issuance targets will not exceed 35, and the funds will be used for innovative drug research and development, the renovation and expansion of raw material drug production, and technical transformation projects for freeze-drying workshops, as well as to supplement working capital
Log in to access the full 0 words article for free
Due to copyright restrictions, please log in to view.
Thank you for supporting legitimate content.
Source: Zhitong The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments